Literature DB >> 19434925

Controlling plasma protein binding: structural correlates of interactions of hydrophobic polyamine endotoxin sequestrants with human serum albumin.

Thuan B Nguyen1, E V K Suresh Kumar, Diptesh Sil, Stewart J Wood, Kelly A Miller, Hemamali J Warshakoon, Apurba Datta, Sunil A David.   

Abstract

Hydrophobically substituted polyamine compounds, particularly N-acyl or N-alkyl derivatives of homospermine, are potent endotoxin (lipopolysaccharide) sequestrants. Despite their polycationic nature, the aqueous solubilites are limited owing to the considerable overall hydrophobicity contributed by the long-chain aliphatic substituent, but solubilization is readily achieved in the presence of human serum albumin (HSA). We desired first to delineate the structural basis of lipopolyamine-albumin interactions and, second, to explore possible structure-activity correlates in a well-defined, congeneric series of N-alkyl and -acyl homospermine lead compounds. Fluorescence spectroscopic and isothermal titration calorimetry (ITC) results indicate that these compounds appear to bind to HSA via occupancy of the fatty-acid binding sites on the protein. The acyl and carbamate compounds bind HSA the strongest; the ureido and N-alkyl analogues are significantly weaker, and the branched alkyl compound is weaker still. ITC-derived dissociation constants are weighted almost in their entirety by enthalpic deltaH terms, which is suggestive that the polarizability of the carbonyl groups facilitate, at least in large part, their interactions with HSA. The relative affinities of these lipopolyamines toward HSA is reflected in discernible differences in apparent potencies of LPS-sequestering activity under experimental conditions requiring physiological concentrations of HSA, and also of in vivo pharmacodynamic behavior. These results are likely to be useful in designing analogues with varying pharmacokinetic profiles.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19434925     DOI: 10.1021/mp8001123

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  9 in total

1.  Structure-activity relationships in toll-like receptor 2-agonists leading to simplified monoacyl lipopeptides.

Authors:  Geetanjali Agnihotri; Breanna M Crall; Tyler C Lewis; Timothy P Day; Rajalakshmi Balakrishna; Hemamali J Warshakoon; Subbalakshmi S Malladi; Sunil A David
Journal:  J Med Chem       Date:  2011-11-04       Impact factor: 7.446

2.  Structure-activity relationships in human toll-like receptor 7-active imidazoquinoline analogues.

Authors:  Nikunj M Shukla; Subbalakshmi S Malladi; Cole A Mutz; Rajalakshmi Balakrishna; Sunil A David
Journal:  J Med Chem       Date:  2010-06-10       Impact factor: 7.446

3.  Structure-activity relationships in nucleotide oligomerization domain 1 (Nod1) agonistic γ-glutamyldiaminopimelic acid derivatives.

Authors:  Geetanjali Agnihotri; Rehman Ukani; Subbalakshmi S Malladi; Hemamali J Warshakoon; Rajalakshmi Balakrishna; Xinkun Wang; Sunil A David
Journal:  J Med Chem       Date:  2011-02-07       Impact factor: 7.446

4.  Structure-activity relationships in toll-like receptor-2 agonistic diacylthioglycerol lipopeptides.

Authors:  Wenyan Wu; Rongti Li; Subbalakshmi S Malladi; Hemamali J Warshakoon; Matthew R Kimbrell; Michael W Amolins; Rehman Ukani; Apurba Datta; Sunil A David
Journal:  J Med Chem       Date:  2010-04-22       Impact factor: 7.446

5.  Toll-like receptor-8 agonistic activities in C2, C4, and C8 modified thiazolo[4,5-c]quinolines.

Authors:  Hari Prasad Kokatla; Euna Yoo; Deepak B Salunke; Diptesh Sil; Cameron F Ng; Rajalakshmi Balakrishna; Subbalakshmi S Malladi; Lauren M Fox; Sunil A David
Journal:  Org Biomol Chem       Date:  2013-02-21       Impact factor: 3.876

6.  Structure-activity relationships of lipopolysaccharide sequestration in N-alkylpolyamines.

Authors:  Anurupa Shrestha; Diptesh Sil; Subbalakshmi S Malladi; Hemamali J Warshakoon; Sunil A David
Journal:  Bioorg Med Chem Lett       Date:  2009-03-18       Impact factor: 2.823

7.  Tumor- and mitochondria-targeted nanoparticles eradicate drug resistant lung cancer through mitochondrial pathway of apoptosis.

Authors:  He Wang; Fangke Zhang; Huaying Wen; Wenwen Shi; Qiudi Huang; Yugang Huang; Jiacui Xie; Peiyin Li; Jianhai Chen; Linghao Qin; Yi Zhou
Journal:  J Nanobiotechnology       Date:  2020-01-09       Impact factor: 10.435

8.  Potent adjuvanticity of a pure TLR7-agonistic imidazoquinoline dendrimer.

Authors:  Nikunj M Shukla; Deepak B Salunke; Rajalakshmi Balakrishna; Cole A Mutz; Subbalakshmi S Malladi; Sunil A David
Journal:  PLoS One       Date:  2012-08-28       Impact factor: 3.240

9.  Biophysical mechanisms of the neutralization of endotoxins by lipopolyamines.

Authors:  Diptesh Sil; Lena Heinbockel; Yani Kaconis; Manfred Rössle; Patrick Garidel; Thomas Gutsmann; Sunil A David; Klaus Brandenburg
Journal:  Open Biochem J       Date:  2013-09-30
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.